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Retroviral and adenoviral vectors have been chosen as effective delivery vehicles for therapeutic genes. However, they have limited effectiveness due to lack of specificity and potential toxicity. Radiation can enhance gene therapy by both the killing effect of irradiation (IR) and the targeting potential of radiation to regulate gene transcription. 2 One of the genes activated by radiation is the early growth response gene Egr-1 (synonyms are NGFI-A, zif268, TIS8, krox24), 3 which encodes a 533-amino-acid phosphoprotein transcription factor. The promoter sequence contains a transcription factor binding site designated the serum responsive element. This motif with its consensus sequence CC(A/T) 6 GG, termed ''CArG'' box, within the promoter region was identified as the radiation-inducible DNA element 4 targeted by reactive oxygen intermediates. 5 The usage of a radiationinducible promoter/enhancer is particularly interesting as it opens the possibility to put gene expression under the spatial and temporal control of radiation. 2 The feasibility of this new approach has been demonstrated in different tumor models. [6] [7] [8] [9] [10] [11] Interference of viral promoters has been observed when using adenoviral vectors in combination with tissue specific promoters. 12, 13 This interference may affect the tissue specificity or inducibility of heterologous promoters. 12 Most Ad vectors contain viral regulatory sequences in their left end (nt 1-341) and in the E2 and E4 promoters that have been shown to interfere with tissuespecific expression from a heterologous promoter. The E1A enhancer cannot be removed from Ad vectors as it overlaps with sequences required for packaging of viral genomes.
In order to overcome the problem of nonspecific gene expression, sequences from the bovine growth hormone polyadenylation signal (BGH pA) or the chicken b-globin gene, respectively, have been used to restore tissue selectivity of promoters in an adenoviral background.
transcription. The transcriptional control of the Egr-1 promoter is not clearly understood. It has been found to be leaky in the context of many other vector systems and the relative contribution of interference from viral promoters remains to be defined.
We are interested in the efficacy and specificity of radiation-inducibility of the EGR-1 promoter, with low doses of IR. We here report on in vitro experiments in rhabdomyosarcoma cells of the rat, which were transduced with the Herpes simplex virus type 1 thymidine kinase (HSV-TK) gene under control of the radiationinducible EGR-1 promoter by an adenoviral vector and treated with ganciclovir (GCV) and IR. The influence of insulators on nonspecific gene expression in the absence of IR and inducibility with small doses of IR was investigated. We show that EGR-1 can be induced by small doses of IR and nonspecific gene expression in the absence of IR can be reduced significantly without compromising radiation-inducibility of the promoter.
Materials and methods

Cells, tissue culture and viral infections
The experiments were performed on rhabdomyosarcoma R1H tumor cells of the rat. The tumor was derived from the rhabdomyosarcoma R-1.
14 Originally the R-1 tumor was derived from the BA 1112 tumor, which appeared spontaneously in 1962 in the musculature of a Wistar rat that had been irradiated 8 months before. 15 Professor Jung, UKE Hamburg, kindly provided the R1H in 1999.
Adenoviral vector packaging 293 cells (Microbix, Toronto, Canada) were cultivated in MEM medium supplemented with glutamine and 10% fetal calf serum (FCS). Vector amplification was in MEM medium with glutamine and 5% heat inactivated horse serum. R1H rhabdomyosarcoma cells were routinely cultivated in DMEM medium supplemented with glutamine and 10% FCS. During infection and IR experiments serum concentration was reduced to 5% FCS.
Vector construction
All restriction enzymes were obtained from Roche Biochemicals or New England Biolabs. Standard DNA manipulations were according to Sambrook et al. 16 Adenoviral shuttle vectors consist of the left end of the Ad genome. pMA41 was derived by digestion of pMA9 17 with BamHI and subsequent religation. The resulting vector has the E1 region substituted by the human CMV promoter, a multiple cloning site and an SV40 polyadenylation signal.
Control plasmids containing the CMV promoter were obtained by insertion of the XbaI fragment of pEGFP (Clontech), carrying the EGFP cDNA into the corresponding site of pMA41 to yield pSW9 or an EcoRI-HindIII fragment carrying the HSV-TK cDNA to yield pSW15.
The murine EGR-1 promoter containing XbaI-SalI fragment of pE425 18 was subcloned into plasmid pDE1-sp1A 19 XbaI-SalI to yield pTvL1. The SV40 polyadenylation signal was added by joining the ScaI-SalI fragment containing the SV40 pA of pMA41 to the ScaI-XhoI fragment of pTvL1 containing the EGR promoter sequence. The resulting plasmid was called pTvL2. The EGFP containing XbaI fragment of pEGFP was blunt ended with Klenow enzyme and cloned into the EcoRV site of pTvL2, to yield pTvL3. The HSV-TK cDNA was subcloned from pSW15 by EcoRI-HindIII digest and inserted accordingly into pTvL2 to obtain pTvL4. The BGH pA was used as insulating sequence and was obtained from pRc/RSV (Invitrogen, Groningen, Netherlands). The XhoI fragment containing the BGH pA was inserted into the unique XhoI site 5 0 of the Egr1-promoter of pTvL3 to yield pTvL6. Additionally the BGH pA containing BamHI fragment of pRc/RSV was inserted into the BglII site 3 0 of the SV40 pA in an antiparallel orientation (to prevent possible influence of down stream vector sequences) after partial digestion of pTvL6. The resulting plasmid was pTvL7. pIEOG1 containing the HSV-TK gene under control of the Egr1-promoter and an 5 0 insulating sequence was constructed by substituting the EGFP carrying BglII fragment of pTvL6 by the HSV-TK containing BamHI-BglII fragment of pSW15. For pIEOG2 the BamHI-HindIII fragment of pSW15 was introduced into BglII-HindIII cut pTvL7 to replace EGFP by HSV-TK. Integrity and orientation of inserts and insulating sequences were verified by DNA sequencing.
Adenoviral vector construction by cotransfection of shuttle vectors (pSW9, pSW15, pTvL3, pTvL4, pIEOG1, pIEOG2, respectively) and Ad backbone plasmid pBHG10 into 293 cells was performed according to Hitt et al 20 and yielded AdCMV.EGFP (from pSW9), AdCMV.TK (from pSW15), AdEGR.EGFP (from pTvL3), AdEGR.TK (from pTvL4), AdI-EGR.TK (from pIEOG1) and AdI-EGR.TK-I (from pIEOG2), respectively. Identity of Ad vectors was confirmed by restriction enzyme digests. High titer stocks were prepared as described 20 and plaque-forming units per ml (pfu) were determined.
A schematic presentation of the left ends of replication defective Ad vectors carrying the HSV-TK expression cassette, and insertions of insulating sequences is given in Figure 1 .
Infection and IR experiments
Cells were irradiated in vitro under ambient conditions with 6 MeV photons of a linear accelerator or 70 kV Xrays. Single doses of 0 Gy (control) to 6 Gy were given. Cells were kept at room temperature during IR.
For infection and IR experiments using EGFP expressing Ad, 10 5 cells were seeded in six-well plates. At 15-20 hours later, cells were infected at an multiplicity of infection (MOI) of 25, respectively, in 500 ml PBS 2 þ /well for 30 minutes at 371C, subsequently fed with medium containing 5% FCS and irradiated 3 hours later.
For infection and IR experiments using TK expressing Ad, 7.5 Â 10 3 cells were seeded in 24-well dishes. The next day infections were performed at an MOI of 10 in a total Radiation controlled gene expression M Anton et al volume of 200 ml PBS 2 þ per well. A measure of 1 ml medium containing GCV (Cymeven, Roche Pharma, Grenzach-Whylen) at 1 mg/ml was added and 3 hours postinfection cells were irradiated. Additional doses of GCV were given 48 and 96 hours later where appropriate and staining of cells was performed by adding a solution of 3% formaldehyde, 5% glacial acetic acid, 50% ethanol, 1.15% crystal violet for 10 minutes and extensive washing 5 days postinfection/IR. Stained cells were counted at 200-fold magnification. For each sample, 10 randomly chosen fields were counted and the nonirradiated, uninfected sample was set to 100%.
FACS analysis
For FACS analysis, cells were plated in triplicates in six wells, infected and irradiated as described above. EGFP expression was monitored 15 or 20 hours post-IR by FACS analysis of trypsinized cells with a fluorescence activated cell sorter (Becton, Dickinson FACS Vantage, Heidelberg, Germany) using Argon Laser beam (Spectra -Physics) of excitation energy 40 mW at 488 nm and the CellQuest Software. In order to detect low levels of gene expression, cellular autofluorescence was subtracted by two-color compensation: two band-pass filters in the green (530/30 nm; FL1) and red (630/22 nm; FL3) channels were used to measure logarithmic amplification of the FL1 and FL3.
In the SSC vs. FSC plot mock treated parental cells were used to define a cell population (R1). In the FL1 vs. FL3 plot, a polygonal region (R3) was defined as gate R3 so as to exclude any nonexpressing cells. All cells that were part of R3 and R1 were used for quantification and are expressed as % gated.
Northern blot analysis
Total RNA of 2 Â 10 6 infected and irradiated or nonirradiated cells was prepared using the RNeasy Mini Kit and QIAshredder (Qiagen, Hilden, Germany), according to the manufacturer's instructions. RNA was separated on denaturing agarose gel, transferred to GeneScreen hybridization transfer membrane (Perkin Elmer Life Sciences, Zaventem, Belgium). The HSV-TKcontaining EcoRI-HindIII fragment of pSW15 was labeled with a 32 P-dCTP (ICN; Germany) using the Prime-It II Random Primer labeling Kit (Stratagene, Germany). Loading control was with an 18 S-coding DNA fragment. Membranes were exposed to FLA-2000 PhosphoImager (raytest, Straubenhardt, Germany). Expression was quantitated using the AIDA software (raytest, Straubenhardt, Germany). HSV-TK expression was normalized to the respective 18S signal. The ratio of irradiated vs. nonirradiated HSV-TK samples was calculated.
Statistical analysis
Data were pooled from two to three independent experiments. Results are presented as means and SD. Statistical analyses were performed using unpaired t-test. A P-value o.05 was considered significant.
Results
EGFP expression under control of CMV or EGR-1 promoter
Representative examples of FACS analyses are shown in Figure 2a . In Figure 2b , EGFP expression of R1H cells, infected with AdEGR.EGFP, AdCMV.EGFP (control virus) or uninfected control (PBS) is shown after no IR or 6 Gy IR. EGFP expression was found in 59.9% (SD71.3%) of AdCMV.EGFP infected cells (control virus), which increased significantly to 71.2% (71.8%) after 6 Gy IR (P ¼ .0008). Nonspecific EGFP expression was observed in unirradiated, AdEGR.EGFP infected tumor cells with 14.1% (70.6%) of cells showing EGFP expression increasing significantly to 29.4% (70.3%) after 6 Gy IR (Po.0001).
AdEGR.EGFP infected R1H cells demonstrated radiation dose-dependent reporter gene expression with 7.2% at 0 Gy, 11.7% at 2 Gy, 15.1% at 4 Gy and 17.6% at 6 Gy, respectively, 15 hours after IR. This results in a 1.6-, 2.1-and 2.5-fold induction of EGFP expression at 2, 4 and 6 Gy, respectively (Fig 3) .
Radiation inducible expression of HSV-TK and cell killing
Egr-1 driven expression of HSV-TK was analyzed by Northern blot at early times after infection and IR. R1H, infected with AdEGR.TK, showed an induction of gene expression after IR with 6 Gy of 1.8-fold over the nonirradiated control (Fig 4) . In contrast, CMV-promoter driven expression of HSV-TK showed a 1.2-fold increase.
Radiation-induced cytotoxicity delivered by AdEGR.TK and GCV was also compared to cell killing delivered by the constitutive human cytomegalovirus immediate early promoter (CMV) (Fig 5) . After treatment (Fig 5) .
Introduction of insulating sequences to reduce background expression in the absence of IR
The BGHpA was chosen as insulating sequence and was either introduced upstream of the EGR promoter or upstream and downstream of the EGR/HSV-TK/SV40pA expression cassette to avoid transcriptional activation from E1A enhancer sequences (upstream) or E2/E4 promoter/enhancer sequences (downstream) (Fig 1) . Introduction of an insulating sequence upstream of the EGR-promoter resulted in an induction of HSV-TK mRNA after IR with 6 Gy as compared to nonirradiated cells by a factor of 2.3 and a factor of 3.0 after introduction of two insulating sequences at early times after infection (Fig 4) . Insertion of an insulator upstream of the expression cassette reduced the nonspecific cytotoxicity by a factor of 1.6 in nonirradiated samples (54.1713.4% surviving cells) Figure 5 . Inducibility of the EGR-promoter by IR with 6 Gy was not impaired with one insulator (18.275.0% with one insulator vs. 17.375.3% without insulator). Additional introduction of a downstream insulator further decreased nonspecific gene expression resulting in 75.8% (718.0%) surviving cells in the absence of IR (decrease of a factor of 2.3 compared to no insulator). The inducibility of the promoter was modestly but significantly decreased (21.973.3% surviving cells after 6 Gy IR as compared to Egr 6 Gy IR; P ¼ .0014). However, the relative difference in surviving tumor cells between nonirradiated and irradiated cells was highest with the introduction of two insulators.
Discussion
The combination of the radiation-inducible AdEGR.TK construct and IR resulted in a significant increase in cell kill as compared to IR alone and was surprisingly strong after induction by IR (Fig 5) . Gene expression, as determined by reporter gene expression, was increased in a radiation dose-dependent manner (Fig 3) . However, the EGR promoter/enhancer was rather strongly induced in the absence of IR (Figs 2b and 5 ). This leakiness of the expression cassette limits the efficacy of temporal and spatial gene targeting by IR, at least in the R1H tumor cell line. However, introduction of insulating sequences reduced this leakiness, while retaining the inducibility of the system (Fig 5) .
Several investigators used the radiation-inducible EGR promoter to control gene expression in a variety of tumor cells in vitro and in vivo and with different vector systems. Hallahan et al 2 linked the EGR promoter to the gene encoding TNF-a and transduced the human squamous carcinoma cell line SQ-20B growing in nude mice with a replication-deficient adenovirus. Compared to 50 Gy alone (given in 5 Gy fractions four times weekly), the combination of Ad5.Egr-TNF and 50 Gy produced a higher growth delay of tumors. Injection of Ad5.Egr-TNF alone with 2 Â 10 8 pfu for 2 weeks twice weekly induced a similar tumor growth reduction up to 4 weeks after initiation of treatment as the combination of Ad5.Egr-TNF and 50 Gy. This indicates TNF-induction in the absence of radiation. No increased soft tissue toxicity was detected in the combined treated animals in comparison to IR alone. Seung et al 21 applied the same EGR-TNFa construct and transfected a murine fibrosarcoma cell line using cationic liposomes. They demonstrated a significant increase in growth delay with the combination of intratumoral injection of the EGR-TNFa and a single dose of 20 Gy IR as compared to IR or EGRTNFa alone up to about 3 weeks after treatment. The effect was more pronounced in larger than in small tumors. A significant increase in the number of thrombotic vessels resulting in necrotic regions was present in the combined treated tumors. 10 A hepatocellular carcinoma was transfected with EGR-TK and became highly sensitive to GCV after IR but not without IR. 7 TK mRNA expression was found 3 hours after IR and reached a maximum 12 hours after IR. However, a 40% growth suppression of hepatoma cells transfected with EGR-TK and exposed to GCV was observed in the absence of IR. In vivo, a significant growth delay could be achieved with EGR-TK and GCV without IR as compared to EGR-TK (stably) transfected and irradiated (20 Gy single dose) tumors. In combining gene therapy and IR tumors regressed almost completely after 3 weeks. As was observed in our in vitro experiments, the nonspecific induction of TK-gene expression in vivo is also considerable. An increase of about three-fold in lacZ transgene activity was observed in 9L glioma cells infected by a replication-deficient adenovirus and irradiated with 2 or 4 Gy 8 in vitro. IR of intracerebral 9L tumors transfected with AdEGR/lacZ also increased b-galactosidase expression.
All these studies provide evidence that vectors containing the radiation-inducible EGR promoter can be used to control gene expression by small doses of IR. However, it seems that its activation is not as tightly regulated by IR as needed and background expression of transgenes in the absence of IR might be a problem. The background expression might be either due to intrinsic leakiness of the promoter or due to the presence of viral enhancer sequences inducing transgene expression.
A series of experimental results addressing the optimization of radiation-inducible gene expression using the CArG elements of the EGR-1 promoter have been published. For example Scott et al 22 constructed synthetic promoters carrying four, six, nine and 12 tandem-repeat copies of the prototype CArG sequence. MCF-7 cells were transfected by reporter plasmids containing the A molecular switching device based on the Cre/loxP switsch system and a synthetic radiation-responsive enhancer was constructed by the same group. 23 MCF-7 cells were stably transfected with the molecular switching device, then transfected with HSVtk-coding sequence and irradiated with doses as low as 1 Gy. The cell growth inhibition was equivalent to 3 Gy IR alone.
Another group used synthetic elements of the EGR-1 enhancer combined with a minimal CMV-promoter to drive reporter gene expression in stably transfected head and neck carcinoma cell lines. However, this construct revealed only weak gene induction and was marked by high background expression. 24 Vassaux et al 13 demonstrated that the introduction of an insulating sequence from the BGH pA restored tissue specificity of the ERBB2 promoter to ERBB2 expressing cells in an adenoviral vector. Steinwaerder and Lieber 12 observed an influence of both upstream and downstream sequences. Our results demonstrate a major influence of the upstream E1 enhancer sequence, as well as downstream promoter/enhancer elements of adenoviral vectors. These seem to override the radiation inducibility of the EGR promoter/enhancer in producing background expression in the absence of IR. Insertion of BGH pA restored the radiation inducibility of EGR-carrying adenoviral vectors. Although treatment with a vector carrying two insulators and IR reduced cell killing slightly, but significantly, the overall difference in cell killing (6 vs. 0 Gy) was highest after introduction of two insulators. Thus, we here demonstrate for the first time that radiation inducibility of EGR promoter/enhancer can be restored by BGH pA as insulating sequences in adenoviral vectors.
The remaining gene expression in the absence of IR is most probably due to an intrinsic leakiness of the EGR promoter. The EGR promoter can be induced by a variety of extracellular stimuli, for example, hypoxia, cytokines and growth factors. 25 Buvoli et al 26 most recently described the reduction of gene expression of the a-myosin heavy chain promoter downstream of a BGH pA in an adenoviral vector in vivo. Whether the introduction of BGH pA as insulating sequences in vivo will allow or abolish gene expression in our system will have to be determined.
Furthermore, we found that the CMV promoter consistently shows significant radiation inducibility. This has been reported previously in hepatocellular carcinoma cells 7 and cholangiocarcinoma cells in vitro and in vivo.
27
In conclusion, combining insulating sequences with the EGR promoter allows tighter regulation of gene expression than the CMV promoter, and thus potential protection of the surrounding nonirradiated tissue.
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